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Delirium in the ICU is under-diagnosed. We evaluated feasibility and performance of a novel 
smartphone-based test for objectively detecting inattention in delirium. 
  
Material and Methods 
DelApp-ICU combines a behavioural assessment and an attention task, whereby participants 
follow simple commands and count serially presented circles (score range 0-12, lower scores 
indicating worse performance). We assessed feasibility through staff interviews. Then we 
performed a preliminary case-control study in patients with and without delirium (ascertained 




Forty-six patients (median age=57.5 years, range 18–83) were assessed 89 times in 
total (N's=46, 29, 10 and 4 for subsequent assessments; 33.7% delirious). DelApp-ICU scores 
were lower in delirium (N=20; median=0.5, Inter-Quartile Range (IQR)=0-4.75) compared to 
no delirium (N=26, median=12, IQR=8-12) on days 1, 2 and 3 (p<0.001, p<0.001 and 
p<0.05, respectively). A DelApp-ICU score ≤6 was 100% sensitive and 96% specific to 
delirium on day 1. Positive and Negative Predictive Values were 91% and 100%, 






DelApp-ICU shows promise for assessing inattention and delirium in ICU patients, including 
longitudinally monitoring deficits and providing a metric of delirium severity. 
 







Delirium is an acute, serious neuropsychiatric disorder which occurs in up to 80% of 
ventilated patients in the ICU [1]. Delirium in ICU patients is associated with adverse 
outcomes including longer hospitalisation, higher medical costs, increased mortality and 
greater risk of developing long-term cognitive impairment, particularly when the delirium has 
a prolonged duration [2-5]. Delirium detection requires accurate assessment of disturbances 
in level of arousal and attention, as well as determining the onset of these features. Further, 
using a longitudinal assessment method which has high validity and reliability which is 
responsive to change is crucial for tracking the time course of delirium [6, 7]. Timely 
diagnosis of delirium is vital to allow early intervention and effective management of 
precipitants and distressing symptoms common in delirium [8-10]. However, despite its 
clinical importance, delirium in the ICU often remains undetected [2]. 
 
The most commonly used tools used for the detection of ICU delirium are the Confusion 
Assessment Method for the ICU (CAM-ICU [1, 11]) and the Intensive Care Delirium 
Screening Checklist (ICDSC [12]).Whereas the initial validation studies of these tools have 
shown high sensitivity, specificity and inter-rater reliability for the detection of delirium, 
others have reported that diagnostic accuracy is partly dependent on tester expertise [13, 14]. 
A recent multi-centre study found that the CAM-ICU had excellent specificity and moderate 
sensitivity in routine practice [15]. 
 
We previously developed a novel computerised test of attention implemented on a custom-
built hardware device termed the Edinburgh Delirium Test Box (EDTB), which successfully 
quantifies inattention using a counting up task paradigm. It has been found to differentiate 
 6 
between general ward patients with and without delirium [16, 17]. A pilot study using a 
modified paradigm (EDTB-ICU) suggested that this test also performs well in detecting 
delirium in ICU patients with RASS> -3. The EDTB-ICU also showed promising utility for 
longitudinally tracking attentional deficits [18]. 
 
Although the EDTB-ICU showed excellent performance, it is clear that tests on devices that 
are universally available, such as smartphones, would be more readily applicable in research 
and clinical settings. Therefore, we developed a software application for detecting deficits of 
visual sustained attention in delirium (DelApp) based on the EDTB paradigm. A preliminary 
study demonstrated initial feasibility of DelApp and excellent accuracy for discriminating 
delirium from dementia and cognitively unimpaired general ward patients [19]. 
 More recently we have developed a modified DelApp for use in ICU settings. The 
DelApp-ICU is based on the EDTB-ICU [18]; it includes a brief behavioural assessment and 
is suitable for use in non-verbal patients. 
 The aim of this preliminary study was to evaluate feasibility and performance of the 
DelApp-ICU as a novel instrument for detecting and monitoring both level of arousal and 
inattention in delirium in ICU patients. First, we evaluated feasibility of the DelApp-ICU 
through interviews with ICU staff, followed by a case-control study of the performance of the 












Participants. Patients admitted to the general ICU of the Royal Infirmary of Edinburgh were 
screened for eligibility. Exclusion criteria were age under 18 years, known pre-existing 
cognitive impairment, brain injury, visual or hearing impairments severe enough to preclude 
cognitive testing, and photosensitive epilepsy. Patients with a Richmond Agitation and 
Sedation Scale Score (RASS) of ≤ -3 (any movement (but no eye contact) to voice) [20] were 
excluded so as to align with the criteria of a previous study [18], and because this was an 
exploratory study, we wanted to include as many ICU patients in our sample able to undergo 
the sustained counting task (Figure 1). The sample size was determined based on a previous 
pilot study using the EDTB-ICU, where large effect sizes were found [18]. 
 
Measurements and procedures. Patients were assessed routinely for delirium with the 
CAM-ICU [11] and RASS [20] by clinical staff trained in using these instruments. The 
researcher recording the reference standard was not blinded to CAM-ICU status. 
Additionally, the Observational Scale of Level of Arousal (OSLA) was used by the 
researchers to provide a more fine-grained measure of level of arousal [16]. Higher scores on 
the OSLA indicate greater abnormality in level of arousal (range = 0 - 15). The Acute 
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Physiology Age and Chronic Health Evaluation (APACHE-II) score was derived from the 
case notes [21].  
 DelApp-ICU assessment. The DelApp-ICU commenced with a behavioural 
assessment to determine the participant's level of arousal and basic orienting response (a 
component of attention), and to select a suitable means of non-verbal communication if 
required from the following possible response methods: pointing, thumbs up, squeezing the 
administrator’s hand, nodding, or sticking one’s tongue out. Next, the ability to track the 
assessor’s moving finger for a period of 5 seconds was determined. Finally, the participant's 
capacity to follow instructions was assessed by instructing them to identify a given number 
on a response card held in front of them by the assessor. The A4-sized laminated response 
card contained the numbers ‘3, 4, 5, 6’. The assessor would point to each of the numbers and 
ask the participant to indicate when the number corresponding to the correct answer was 
pointed out via verbal or non-verbal (as mentioned above) methods. The maximum possible 
score for this behavioural assessment was 3. 
 
Next, a visual task was presented on the 9.2 x 5.9 cm display of a Samsung Galaxy S2 
smartphone running the Android 3.2 operating system, held at a distance of approximately 30 
cm from the participant's eyes. This task consisted of four short trials which required 
participants to (1) identify a change in colour of a circle (5 cm diameter) presented on the 
smartphone screen from white to grey or vice versa (trials 1 and 2) and (2) identify a change 
in the shape of the stimulus from circle to star or vice versa (trials 3 and 4). For both these 
trials, participants were asked to indicate verbally or non-verbally (using the method selected 
during the behavioural assessment) when they noticed a change in colour or shape. 
 Participants then proceeded with the visual sustained attention task, which was 
deemed to place relatively high demands on attentional functioning whilst being of low 
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overall task complexity. Brightness was set automatically based on the ambient light. The 
target stimulus, a large white circle (5 cm diameter), was displayed in the centre of the 
smartphone screen against a black background and would be intermittently displayed (i.e. 
appear and disappear) a number of times throughout the trial. On some trials, the circle was 
surrounded by pseudo-random subsets of 8 small downward-pointing triangles (0.3 x 0.3 x 
0.4 cm), each presented for 500 or 700ms duration, to provide distraction (see Supplementary 
Material). Participants were instructed to count the number of times the circle was shown and 
to ignore any triangles which may appear in later trials. For each trial, when asked by the 
assessor how many circles were shown, participants responded either verbally, or by selecting 
an answer from four possible answers presented on the response card using non-verbal 
methods.  
 The counting task comprised a practice trial (which was not scored) and nine scored 
trials. On all trials, target lights were presented between 3 and 6 times per trial for a fixed 
duration of 1000ms, with an inter-stimulus interval of 1000ms, 2000ms, or 3000ms which 
varied across trials. The trials were presented in a fixed order. The practice trial consisted of a 
white circle which was displayed three times at a fixed inter-stimulus interval of 2000ms with 
concurrent presentation of distracters (700ms duration each). If the participant answered 
incorrectly, the practice trial was repeated once more before proceeding with the nine 
remaining trials. All responses were recorded and scored as correct or incorrect; if no 
response was given then this was scored as an error. 
 
Total DelApp-ICU score was calculated as the summed score of the behavioural assessment 
(0-3) and the sustained attention test (0-9), yielding a total score ranging between 0 (severe 
attentional deficits) and 12 (no attentional deficits) (Figure 2). 
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A pilot study in 10 non-delirious verbal ICU patients was conducted as the ethics committee 
ruled it unnecessary to involve patients requiring proxy consent at that stage. All participants 
obtained the maximum possible score of 3 for the behavioural assessment, and all completed 
the attention task with 6 out of 10 participants making no errors. Thus, the DelApp-ICU was 
found to be feasible for use in the ICU setting in non-intubated patients without delirium. 
 
Assessment of staff acceptability. Twenty-two ICU staff were interviewed using a semi-
structured format in order to gain insight into (i) perceptions on delirium assessment in 
routine clinical work; and (ii) opinions on the feasibility of using a smartphone application in 
the ICU for the assessment of delirium. The ICU staff interviews focused on general 
knowledge of delirium, opinions on the use of CAM-ICU for routine screening of delirium, 
and opinions on the use of smartphone apps in general and specifically the DelApp-ICU for 
delirium assessment (see Supplementary Material). Nurses were shown the DelApp-ICU 
during the interview. Staff interviews were audio-recorded and transcribed, and responses 
were grouped according to pre-defined themes. 
 
Longitudinal case-control study. This was a prospective case-control study of ICU patients 
who were recruited into groups with and without delirium at the time of study entry. All 
patients underwent the DelApp-ICU at the initial assessment and then underwent up to 3 
further assessments on separate days, only if the patient remained in the ICU at the time of 
further assessments and if they, their next of kin and/or the healthcare team agreed to 
continued participation. The longitudinal design was used to evaluate the performance of the 
DelApp-ICU for quantifying fluctuations in attention impairments and delirium over time. 
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 Five sets of the DelApp-ICU counting task were constructed to administer to patients 
undergoing longitudinal assessments, to minimize practice effects. Only the number of target 
illuminations, though all between 3-6 illuminations per trial, differed between these sets. All 
patients were assessed using set 1 on the first assessment day; sets 2-5 were administered in a 
randomised manner on subsequent occasions. 
 
Statistical Analysis 
 Non-parametric statistical tests were used because the majority of the data was not 
normally distributed and there were unequal variances across groups. Comparisons of 
DelApp-ICU test scores and all other data were made between groups with and without 
delirium using Mann-Whitney U tests and Chi Square tests. Receiver Operating Curve (ROC) 
analyses were conducted on DelApp-ICU scores on the first assessment day. 
 
 A linear mixed effects model (R function lmer [22]) was fitted to the repeated-
measures data in order to test whether the association between the scores on the CAM-ICU 
and DelApp-ICU varied over time. The model included CAM-ICU score (coded 0 and 1), the 
assessment day (coded 0 to 3), and their interaction as predictors of the DelApp-ICU score. 
The time-varying association between scores on the CAM-ICU and DelApp-ICU was 
allowed to have a random intercept between patients. 
 
 Non-parametric tests (Mann-Whitney U) were used to test for differences between 
patients who completed one assessment and those who completed multiple assessments on a 




Acceptability of DelApp-ICU to clinical staff: Nurse interviews 
 
 Twenty-two ICU staff (20 nurses, one doctor and one nurse practitioner) were 
interviewed. The majority of nurses reported using the CAM-ICU once at the beginning of 
each shift, and would sometimes re-administer this tool if sedation was reduced or in case of 
other changes in patient status such as fluctuations in delirium status. 
 
 Staff opinions of the CAM-ICU were mixed. Most interviewees found the CAM-ICU 
to be a useful, straightforward tool for detecting delirium, but some voiced issues regarding 
its use in clinical practice. These included challenges with test administration due to physical 
weakness of patients, excessive agitation or drowsiness, hearing impairment, or not being 
fluent in English. The CAM-ICU was perceived as sometimes time-consuming and requiring 
a lot of explanation for some patients. Many nurses felt that the use of the CAM-ICU, or any 
other delirium assessment tool, was not necessary because they were able to judge a patient's 
delirium status without using a tool. 
 
 There were varied opinions of the use of smartphone applications in the ICU, and 
specifically the DelApp-ICU. At the time of the study, the use of phones was discouraged on 
the ward and consequently nurses were uncomfortable using a phone in front of visitors. 
Infection control was raised as another issue, if tests running on smartphones were to be used 
between beds. Anonymity of patients was also a concern because of the embedded cameras in 
the phones (even if these were not being used in the test). It was suggested that there would 
need to be at least one smartphone in each ward and preferably one for every bed space to 
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reduce risk of infection. One respondent noted that the use of smartphones could negatively 
impact on the interaction between patient and nurse. 
 There were concerns that older patients might not respond well to a test presented on 
a smartphone and that it could make delirious patients more agitated. It was thought to be 
more suitable for use in younger patients, who might prefer smartphone-based tests over 
more traditional methods of assessment. However, most nurses thought that a smartphone test 
was an innovative way of moving forward. 
 The DelApp-ICU was found to be user friendly, but issues were noted regarding its 
practical application. Poor vision was frequently mentioned as a potential issue, specifically 
glasses not being available or uncomfortable to wear, the presence of cataracts and lack of 
prolonged eye opening or eye contact in many patients due to abnormal arousal and/or 
attention. Some interviewees suggested that a tablet device may be more appropriate as this 
would allow presentation of larger stimuli.  
 
Longitudinal case-control study 
 
Participants. Forty-seven patients were assessed during the main study phase in a period of 
40 testing days. Twenty-one patients were diagnosed with delirium according to the CAM-
ICU on at least one assessment, and 25 patients were never delirious during the study (Table 
1). RASS scores ranged from -2 to +3 (median score = 0). Data from one patient were 
excluded due to uncertain clinical delirium diagnosis. A total of 30 delirious episodes and 59 
non-delirious episodes were analysed. Twelve assessments were performed on ventilated 
patients. Of the 43 repeat assessments, 30 were performed the day after the previous 
assessment, 7 assessments were performed after two days, 3 assessments after three days, and 
1 assessment each after 4, 6 and 9 days (median = 1 day, IQR = 1 - 2). 
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 The DelApp-ICU assessment took approximately 3-8 minutes to administer, 
depending on the level of arousal and responses of the participant.Verbal responses were used 
in 72% of assessments, while pointing was the most common non-verbal method of response 
(7%) followed by hand squeezing (3%), although it was noted that verbal participants 
sometimes used non-verbal responses such as nodding and pointing in addition to speech. 
One ventilated participant used a combination of responses (nodding, pointing, squeezing and 
raising eyebrows). The remaining 18% of participants failed to pass the initial behavioural 
assessment, therefore did not proceed with the sustained attention task. Importantly, all ICU 
patients recruited were able to use the DelApp-ICU demonstrating it is a feasible tool. 
 
DelApp-ICU Performance. Patients with delirium (N = 20) scored significantly lower on 
the DelApp-ICU task (median = 0.5, IQR = 0 – 4.75, range = 0 – 6) compared to patients 
without delirium (N = 26, median = 12, IQR = 8 – 12, range = 5 – 12) on the first assessment 
day (U = 0.5, p < 0.001) (Figure 3). This difference was also evident for the second 
assessment (delirium: N = 8, median = 0, IQR = 0 – 3.75, range = 0 – 6; no delirium: N = 21, 
median = 11, IQR = 8 – 12, range = 4 – 12; U = 3.5, p < 0.001) and third assessment 
(delirium: N = 2, median = 0.5, IQR = 0 – 0, range = 0 – 1; no delirium: N = 8, median = 
10.5, IQR = 8.25 – 11.75, range = 4 – 12; U = 0.00, p < 0.05). No patients were diagnosed 
with delirium at the fourth assessment, precluding group analysis.  
 
 ROC analysis of data from the first assessment showed that DelApp-ICU score was 
successfully able to differentiate between delirious and non-delirious patients (AUC = 0.999 
(95% CI = 0.995 – 1.000), p < 0.001). A score of 6 or less was 100% sensitive and 96% 
specific to delirium on the first assessment, whereas a score of 5 or less was 95% sensitive 
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and 100% specific to delirium. The Positive Predictive Value was 91% and Negative 
Predictive Value was 100% on first assessment for a cut off score of 6 or less. 
 
 The linear mixed-effects model showed that a diagnosis of delirium (according to the 
CAM-ICU) was associated with a decrease in the patient's DelApp-ICU score of -7.46 at the 
time of diagnosis (beta = -7.46, S.E. = 0.64, t (df = 82) = -11.71, p < 0.001) (Figure 4). There 
was no significant interaction between the CAM-ICU effect and the assessment day (beta = 
0.01, S.E. = 0.66, t (df = 51) = 0.02, ns), indicating that the association between CAM-ICU 
and DelApp-ICU scores did not change after the first assessment. 
 There were no differences in age, RASS, OSLA and APACHE II score between those 
who completed only one assessment compared to those who underwent multiple assessments; 







 This preliminary study demonstrated initial feasibility and validity of a smartphone 
test for detecting and monitoring attention and arousal impairments in delirium in the ICU. In 
the present exploratory work, the DelApp-ICU had excellent diagnostic performance in a 
selected sample of ICU patients, consistent with previous findings using a hardware version 
of the test [18]. DelApp-ICU scores were responsive to a within-person change in delirium 
diagnosis according to the CAM-ICU. The DelApp-ICU assessment was found to be suitable 
for use in intubated or otherwise non-verbal patients with varying levels of arousal. 
 
Strengths and limitations 
 
 The DelApp-ICU test appears to have a number of strengths including its ease of use, 
objectivity and portability. It provides a standardised assessment of attention impairment in 
delirium and it requires little training. The DelApp-ICU may be particularly suitable when 
used by non-experts as it does not rely strongly on clinical judgment, reducing assessor bias 
or error [23]. 
 Differing from most existing diagnostic tools whereby attentional function is scored 
in a binary manner, the DelApp-ICU provides a graded measure of attention reflecting the 
continuum of attentional impairment seen in delirium. Indeed, DelApp-ICU scores varied 
across the full range of possible scores (0 – 12) with considerable variation noted even among 
patients with delirium (0 – 6). As such, the DelApp-ICU has potential utility as a valid 
measure of delirium severity, and may be useful in tracking change in presence and severity 
of attention impairments in delirium over time. There is some agreement that quantifying 
severity of delirium in ICU is useful for detecting delirium at an early (possibly prodromal) 
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stage, to assess whether delirium is persistent or resolving over time and consequently inform 
sedation practice, and to provide a means of measuring response to treatment [24]. 
Furthermore, early detection of delirium can minimise the risk of developing any adverse 
outcomes associated with delirium, including prolonged hospitalisation and increased 
mortality.  
 
 A common issue in assessing hospitalised patients for delirium is that impaired level 
of arousal often precludes formal cognitive assessment of its cardinal feature of impaired 
attention, especially in the most vulnerable patients. The DelApp-ICU addresses this issue of 
testability by including a brief assessment of arousal (as part of the behavioural assessment) 
and basic orienting, which is reflected in the total DelApp-ICU score. In other words, all 
patients including those who have difficulty engaging with the task due to drowsiness or 
extreme agitation are assessable with the DelApp-ICU process. 
 
 The study has a number of limitations. A number of potential barriers were identified 
from the nurse interviews, including concerns about patient anonymity, infection control, and 
visual impairments. These would clearly need to be addressed prior to implementation in 
real-world clinical practice. For example, approved processes and safeguards would be in 
place to protect anonymity. Also, clinical staff raised concerns that some patients may be too 
weak to squeeze a hand, potentially limiting feasibility and validity of this response method 
[25]. Of note, the SAVEAHAART, a key part of the CAM-ICU for assessing inattention 
which relies on hand squeezing as method of response, has not been validated on its own for 
use in ICU patients. The suitability of this response method in ICU patients needs to be 
further explored. Nonetheless, overall the DelApp-ICU was found to be a promising tool for 
detecting and monitoring arousal and attention impairments in delirium in the ICU. The use 
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of DelApp and variant tests in several completed and ongoing research studies provides 
evidence supporting its feasibility [16, 18, 30-33].  
A case-control design using a relatively small patient sample was employed and 
patients with a RASS score < -2 were excluded from the study, thereby limiting 
generalisability. The study was not sufficiently powered for the longitudinal analysis. We did 
not compare our findings to a validated measure of delirium severity. The CAM-ICU was 
used as a reference standard for delirium diagnosis. Some studies have reported moderate 
sensitivity of this tool [15]; hence milder forms of delirium may have been missed in the 
present study. Also, the researchers were aware of the CAM-ICU status of patients at the time 
of administering the DelApp-ICU assessment. Although the DelApp-ICU scoring does not 
rely strongly on subjective judgment, we cannot exclude that knowledge of delirium status 
may have influenced DelApp-ICU assessments to some extent. The DelApp-ICU requires 
active task participation, which is a limitation common to most delirium assessment methods. 
However, the DelApp-ICU offers more flexibility through selection of a suitable method of 
response and allows for scoring of markedly drowsy or agitated patients. 
   
Implications for research and clinical practice 
 
 Being an initial exploratory study, further evaluation of the real-world reliability and 
acceptability of the DelApp-ICU as a diagnostic tool for detecting and monitoring attention 
impairments in delirium in the ICU is required. Additional qualitative staff interviews 
specifically focusing on the presentation and usability of the DelApp-ICU should be carried 
out. To assess diagnostic performance and inform optimal cut-points, a larger case-control 
study in ICU patients (including patients with a RASS score <-2) followed by a definitive 
study in a representative sample of ICU patients is required. Such studies should include a 
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more comprehensive reference standard evaluation including detailed assessment of arousal, 
attention (from bedside assessment) and timing of onset (from informants, if available) [26], 
and should have independent assessors administering the index test (DelApp-ICU) and 
reference standard assessment. Ultimately the DelApp-ICU assessment may have 
applications in both clinical practice and research, where it could supplement existing 
instruments or provide an alternative, particularly in cases where monitoring delirium 
severity over time is required. The scalar aspect of the DelApp-ICU may also be useful for 
determining who is at higher risk of delirium as poor premorbid attention has been associated 
with subsequent delirium [27]. 
 The present study also provides preliminary support for the utility of the OSLA as a 
tool for detailed measurement of level of arousal in ICU patients, though the OSLA itself has 
yet to be formally validated in this population. 
 
 Our study fits with the growing trend towards using smartphone-based assessments 
for assessing cognitive function in patients [28]. A meta-analysis of healthcare-related apps 
indicated that the majority of applications were aimed at healthcare professionals focusing on 
disease diagnosis, and highlightedthe use of smartphones as emerging technology for point-
of-care testing in clinical practice [29]. Tools such as the DelApp-ICU may encourage and 
facilitate greater adoption of delirium detection and monitoring, which is a serious and yet 




 This is the first study to provide evidence for the feasibility and initial validity of a 
brief and simple smartphone-based test for quantifying impairments in level of arousal and 
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attention associated with delirium in the ICU. The DelApp-ICU shows promise as an 
objective tool to assist detection of delirium in research, with potential applications in clinical 
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DelApp-ICU = Delirium Software Application for the ICU 
EDTB = Edinburgh Delirium Test Box 




 All patients 
CAM-ICU positive 
on at least one 
assessment 
CAM-ICU negative 
on all assessments 
N 46 21 25 
Age, years (median, 
IQR) 
57.5 (49 - 70) 61 (48 - 77.5) 54 (46.5 - 68.5) 
Sex (female (N, %)) 17 (37.0%) 8 (38.1%) 9 (36.0%) 
APACHE-II Score 14 (12 - 20) 17 (13 - 24.5) 13 (10 - 15) 
ICU length of stay, 
days (median, IQR) 
4.9 (3.0 - 9.9) 6.8 (3.4 - 13.9) 4.3 (2.5 - 8.1) 








N 89 30 59 
Mechanically 
ventilated N, %) 
12 (13%) 8 (26.7%) 4 (6.7%) 
RASS score (N, %)    
+3 1 (1.1%) 1 (3.3%) 0 (0.0%) 
+2 0 (0.0%) 0 (0.0%) 0 (0.0%) 
+1 6 (6.7%)  6 (20.0%) 0 (0.0%) 
 0 64 (71.9%) 13 (43.3%) 51 (86.4%) 
-1 16 (18.0%) 8 (26.7%) 8 (13.6%) 
-2 2 (2.2%) 2 (6.7%) 0 (0.0%) 
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OSLA score (N, %)    
0 43 (48.3%) 2 (6.7%) 41 (69.5%) 
1 - 3 12 (13.5%) 3 (10.0%) 9 (15.3%) 
4 - 6 13 (14.6%) 6 (20.0%) 7 (11.9%) 
7 - 9 10 (11.2%) 8 (26.6%) 2 (3.4%) 
10 - 12 10 (11.2%) 10 (33.3%) 0 (0.0%) 
13 - 15 1 (1.1%) 1 (3.3%) 0 (0.0%) 
Total DelApp-ICU 
score (median, IQR) 
(/12) 




3 (3 - 3) 0.5 (0 - 3) 3 (3 - 3) 
Attention assessment 
subscore (/9) 
5 (0.75 - 9) 0 (0 - 1.25) 8 (5 - 9) 
 
Table 1. Demographic characteristics of participants in the main study and characteristics of 
participants in the main study at each assessment. RASS = Richmond Agitation Sedation 
Scale. OSLA = Observational Scale for Level of Arousal, range 0 - 15 with higher scores 





Figure 1: Recruitment flowchart. 
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Figure 2: Flow diagram of DelApp-ICU testing procedure. All participants undertook a 
behavioural assessment to examine their level of arousal and ability to engage with cognitive 
testing, as well as establishing a feasible method of response. Participants who successfully 





Figure 3: Boxplot illustrating the results of the DelApp-ICU test for patients with and without 
delirium according to CAM-ICU score at 4 assessment days. The median is represented by 
the thick horizontal bars and median values are displayed next to these bars. The interquartile 
range is represented by the height of the inner boxes. The upper and lower whiskers represent 






Figure 4: DelApp-ICU scores across assessments for patients who were assessed when both 
CAM-ICU positive (black circles) and CAM-ICU negative (white circles). DelApp-ICU 
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